Tafalgie Therapeutics
ID: 17900128Tafalgie Therapeutics is a developer of non-opioid treatments for pain founded in 2020 by Eric Schettini.
1
Funding Rounds
$14.2m
Money raised
Recent Funding Rounds
Overview
Tafalgie Therapeutics is a developer of non-opioid treatments for pain founded in 2020 by Eric Schettini.
- Website:
- Headquarters: Marseille
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Er** Sc******* |
|
- | |
| Az** Mo***** |
|
- | - |
Funding series
Funding Series Analysis
The company Tafalgie Therapeutics has raised a total of $14.2m in funding over 1 rounds.
Key Insights:
- Tafalgie Therapeutics Series A Round, September 2025: $14.2m
Industries
Tafalgie Therapeutics is active in the following industries: